Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06215820 · ClinicalTrials.gov registry record · Phase 3
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy
A Phase 3 study, sponsored by Viatris Specialty.
- Completed
- Registry status
- Phase 3
- Development phase
- 410
- Enrollment target
NCT06215820: Completed Phase 3 study, sponsored by Viatris Specialty.
NCT06215820 is a Phase 3 study that has completed, run by Viatris Specialty. The registered enrollment target is 410 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06215820, a Phase 3 study, has completed, sponsored by Viatris Specialty.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 410 participants
- Enrollment target
Study Summary
MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
Primary Outcome
SPID based on a 0 to 10-point numeric rating scale at rest (NRS-R) for MR-107A-02 versus placebo.
Interventions
- DRUG Placebo
- DRUG Tramadol
- DRUG MR-107A-02
- PROCEDURE Bunionectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2023-12-29 |
| Est. Completion | 2024-09-30 |
| Phase | Phase 3 |
What the finished NCT06215820 record still lists
NCT06215820 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT06215820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06215820 about?
NCT06215820 is a clinical study titled "Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy". MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after bunionectomy.
What is the current status of trial NCT06215820?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 410 participants. The study started on 2023-12-29. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT06215820?
The interventions under investigation include: Placebo (DRUG), Tramadol (DRUG), MR-107A-02 (DRUG), Bunionectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06215820?
This trial is sponsored by Viatris Specialty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06215820's enrollment target sits among peer trials
410 909th of 2000 higher than 1,090 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI